Whatman has decided to wind down the operations of its German
subsidiary Biometra, taking a £10.1 million charge in the process.
The move fends off a patent infringement challenge from Applied
Roche Molecular Systems, the in vitro diagnostics element of
Swiss pharmaceutical company Roche said this week that its
supplement to the AMPLICOR(TM) HIV-1 Test, version 1.5 has been
accepted for review by the US Food and Drug Administration...